---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-029096"
form_type: "8-K"
ticker: "VTGN"
cik: "0001411685"
company_name: "Vistagen Therapeutics, Inc."
filed_at: "2023-10-26T23:59:59+00:00"
generated_at: "2026-06-09T08:19:16.429524+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Joshua Prince appointed COO of Vistagen Therapeutics

## Summary
- Joshua Prince appointed Chief Operating Officer effective Oct 24, 2023; had been SVP Business Operations since Nov 2021.
- Prince brings over 20 years pharma experience including roles at CSL Behring, Teva, and AstraZeneca.
- Holds a BS in Mechanical Engineering from Missouri-Rolla and an MBA from Penn State.
- Company entered into standard Indemnification Agreement with Prince for his service.

## SEC filing metadata
- accession: 0001437749-23-029096
- form_type: 8-K
- ticker: VTGN
- cik: 0001411685
- company_name: Vistagen Therapeutics, Inc.
- filed_at: 2023-10-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411685/000143774923029096/0001437749-23-029096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411685/000143774923029096/vtgn20231026_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-029096
- JSON: https://secwatch.observer/filing/0001437749-23-029096.json
- Plain text: https://secwatch.observer/filing/0001437749-23-029096.txt

## Key facts
- Executive change
  Joshua Prince was appointed as Chief Operating Officer at Vistagen Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On October 24, 2023, Joshua Prince was appointed to serve as the Chief Operating Officer of Vistagen Therapeutics, Inc. (the “ Company ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411685/000143774923029096/0001437749-23-029096-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.